UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1948-1957

2019

Volltextzugriff (PDF)

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients

PloS one, 2017-03, Vol.12 (3), p.e0172799-e0172799

2017

Volltextzugriff (PDF)

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival

PloS one, 2017-08, Vol.12 (8), p.e0181615-e0181615

2017

Volltextzugriff (PDF)

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

Journal of clinical oncology, 2016-02, Vol.34 (5), p.501-508

2016

Volltextzugriff (PDF)

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients

Japanese journal of clinical oncology, 2018-07, Vol.48 (7), p.619-624

2018

Volltextzugriff (PDF)

The ethics of deep brain stimulation (DBS)

Medicine, health care, and philosophy, 2015-11, Vol.18 (4), p.475-485

2015

Volltextzugriff (PDF)

Root Resorption Caused by Jaw Infiltration of Multiple Myeloma: Report of a Case and Literature Review

Journal of endodontics, 2014-08, Vol.40 (8), p.1260-1264

2014

Volltextzugriff (PDF)

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer

Oncology research and treatment, 2016-11, Vol.39 (11), p.696-702

2016

Volltextzugriff (PDF)

The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells

British journal of haematology, 2010-05, Vol.149 (4), p.518-528

2010

Volltextzugriff (PDF)

Priority-setting, rationing and cost-effectiveness in the German health care system

Medicine, health care, and philosophy, 2013-08, Vol.16 (3), p.327-339

Oduncu, Fuat S.

2013

Volltextzugriff (PDF)

Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells

Molecular cancer therapeutics, 2009-02, Vol.8 (2), p.366-375

2009

Volltextzugriff (PDF)

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Oncoimmunology, 2018-09, Vol.7 (9), p.e1472195-e1472195

2018

Volltextzugriff (PDF)

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

Acta oncologica, 2016-01, Vol.55 (3), p.318-328

2016

Volltextzugriff (PDF)

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma

Journal of translational medicine, 2014-05, Vol.12 (1), p.119-119, Article 119

2014

Volltextzugriff (PDF)

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells

Oncotarget, 2016-04, Vol.7 (16), p.22579-22589

2016

Volltextzugriff (PDF)

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

Frontiers in hematology, 2024-06, Vol.3

2024

Volltextzugriff (PDF)

Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16

Journal of immunotherapy, 2010-07, Vol.33 (6), p.599-608

2010

Volltextzugriff (PDF)

A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

mAbs, 2014-01, Vol.6 (1), p.286-296

2014

Volltextzugriff (PDF)

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody

Analyst (London), 2016-04, Vol.141 (7), p.2284-2295

2016

Volltextzugriff (PDF)

ITOC2 – 024. Selective lysis of biphenotypic leukaemia cells is mediated by dual-targeting triplebody 33-3-19 treatment

European journal of cancer (1990), 2015-03, Vol.51, p.S9-S9

2015

Volltextzugriff (PDF)

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients

Oncology research and treatment, 2017, Vol.40 (11), p.702-706

2017

Volltextzugriff (PDF)

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell

Oncotarget, 2014-08, Vol.5 (15), p.6466-6483

2014

Volltextzugriff (PDF)

A recombinant triplebody with specificity for CD19 and HLA-DR mediates  preferential binding to antigen double-positive cells by dual-targeting

mAbs, 2012-01, Vol.4 (1), p.45-56

2012

Volltextzugriff (PDF)

Doctor-cared dying instead of physician-assisted suicide: a perspective from Germany

Medicine, health care, and philosophy, 2010-11, Vol.13 (4), p.371-381

2010

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(73)
Deutsch
(27)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Science & Technology
(46)
Life Sciences & Biomedicine
(43)
Oncology
(27)
Female
(20)
Male
(17)
Hematology
(16)
Adult
(13)
Aged
(13)
Middle Aged
(13)
Multiple Myeloma
(13)
Antineoplastic Agents - Pharmacology
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prognosis
(10)
Animals
(9)
Apoptosis - Drug Effects
(9)
Medicine, Research & Experimental
(8)
Neoplasm Staging
(8)
Research & Experimental Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients

The ethics of deep brain stimulation (DBS)

Root Resorption Caused by Jaw Infiltration of Multiple Myeloma: Report of a Case and Literature Review

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer

The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells

Priority-setting, rationing and cost-effectiveness in the German health care system

Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16

A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody

ITOC2 – 024. Selective lysis of biphenotypic leukaemia cells is mediated by dual-targeting triplebody 33-3-19 treatment

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell

A recombinant triplebody with specificity for CD19 and HLA-DR mediates  preferential binding to antigen double-positive cells by dual-targeting

Doctor-cared dying instead of physician-assisted suicide: a perspective from Germany

Suchergebnisse filtern